PACB vs WRB · rev $76.2M vs P/E 17, $27.12B cap
Pacific Biosciences of California (PACB) versus W. R. Berkley Corp (WRB) — a side-by-side from cached financials, not a winner call.
Pacific Biosciences of California (PACB) is a medical devices company listed on US.
W. R. Berkley Corp (WRB) is a insurance - property & casualty company listed on US.
Latest reported PACB revenue for 2026-06-30 was $76.2M. Net income was -$53.0M. PACB currently screens at market cap $387.1M.
WRB does not have a complete income-statement cache yet.
PACB currently screens at market cap $387.1M. WRB currently screens at market cap $27.12B and trailing P/E 16.6.
Not investment advice. Open the PACB and WRB stock pages for the full models.
Not investment advice.